|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Options | $ 0.01 | 01/01/2005 | 01/01/2010 | Common Stock | 400,000 | 400,000 | D | ||||||||
Stock Options | $ 2.5 | 01/01/2006 | 01/01/2011 | Common Stock | 400,000 | 800,000 | D | ||||||||
Stock Options | $ 2.5 | 12/05/2007 | M(4) | 66,000 | 01/01/2006 | 01/01/2011 | Common Stock | 66,000 | $ 2.5 | 734,000 | D | ||||
Stock Options | $ 2.5 | 12/06/2007 | M(4) | 120,160 | 01/01/2006 | 01/01/2011 | Common Stock | 120,160 | $ 2.5 | 613,840 | D | ||||
Stock Options | $ 2.5 | 12/07/2007 | M(4) | 46,000 | 01/01/2006 | 01/01/2011 | Common Stock | 46,000 | $ 2.5 | 567,840 | D | ||||
Stock Options | $ 5 | 01/01/2007 | 01/01/2012 | Common Stock | 400,000 | 967,840 | D | ||||||||
Stock Options | $ 7.5 | 01/01/2008 | 01/01/2013 | Common Stock | 500,000 | 1,467,840 | D | ||||||||
Stock Options | $ 10 | 01/01/2009 | 01/01/2014 | Common Stock | 500,000 | 1,967,840 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Wang Yuejian 5301 N. FEDERAL HIGHWAY SUITE 120 BOCA RATON, FL 33487 |
X | X | CEO, Chairman |
/s/ Yuejian (James) Wang | 12/07/2007 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | 2,100,000 shares were gifted by Dr. Wang to Dragon Fund Management LLC. Dr. Wang holds 1% of the membership interest and 50% of the voting control of Dragon Fund Management LLC. |
(2) | 440,000 shares were gifted by Dr. Wang to Lotus Capital Fund, an irrevocable trust for the benefit of Dr. Wang's wife. Dr. Wang is not a trustee of Lotus Capital Fund and he disclaims beneficial ownership in securities held by Lotus Capital Fund. |
(3) | 1,460,000 shares were gifted by Dr. Wang to Tiger Fund Trust, an irrevocable trust for the benefit of his minor child. Dr. Wang is not a trustee of Tiger Fund Trust and he disclaims beneficial ownership in securities held by Tiger Trust Fund. |
(4) | Dr. Wang exercised options granted to him under an employment agreement with China Direct, Inc. and vested on 1/1/06. Dr. Wang delivered proceeds of $580,400 to China Direct, Inc. Transactions were made pursuant to a duly adopted trading plan under Rule 10b5-1. |